Researchers have developed an artificial intelligence method that can uncover previously hidden signs of multiple sclerosis in routine MRI scans.
AI-enhanced MRI analysis revealed more than 10,000 hidden cortical lesions linked to disability and cognitive problems in ...
IFLScience on MSN
Even mild COVID-19 infections can cause long-term eye problems. But diagnosis may finally be possible
Eye problems such as extreme sensitivity to light and difficulty reading are among the many symptoms of long COVID. But they ...
People (much more often women) have acute attacks of symptoms that stop, and a person recovers partially or completely until ...
Teva secures exclusive global rights to commercialize Polpharma Biologics’ biosimilar candidate to Ocrevus® (ocrelizumab), including both ...
Teva secures exclusive global rights to commercialize Polpharma Biologics' biosimilar candidate to Ocrevus (ocrelizumab), including both intravenous and subcutaneous formulations. Agreement advances T ...
Reports of cases detail the development of thyroid eye disease 3-5 years following treatment of MS with immunomodulatory ...
Teva gains exclusive commercialization rights for IV and SC ocrelizumab biosimilar formulations across the US, Europe, Brazil, Canada, Australia, New Zealand, Israel, and Turkey, pending approvals.
A man living with a chronic autoimmune disease has designed a show garden to provide people with a sense of "peace away from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results